Collegium Pharmaceutical, Inc financial data

Symbol
COLL on Nasdaq
Industry
Pharmaceutical Preparations
Location
100 Technology Center Drive, Stoughton, Massachusetts
State of incorporation
Virginia
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 119 % +15.3%
Quick Ratio 6.86 % -48.1%
Debt-to-equity 483 % -8.57%
Return On Equity 46.8 %
Return On Assets 8.03 %
Operating Margin 33.8 % +161%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 32.7 M shares -5.43%
Common Stock, Shares, Outstanding 32.7 M shares -5.42%
Entity Public Float 742 M USD +23.7%
Common Stock, Value, Issued 39 K USD +2.63%
Weighted Average Number of Shares Outstanding, Basic 32.3 M shares -5.81%
Weighted Average Number of Shares Outstanding, Diluted 41.4 M shares +20.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 567 M USD +8%
Research and Development Expense 0 USD -100%
Operating Income (Loss) 192 M USD +182%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 130 M USD
Income Tax Expense (Benefit) 36.6 M USD
Net Income (Loss) Attributable to Parent 93.3 M USD
Earnings Per Share, Basic 2.84 USD/shares
Earnings Per Share, Diluted 2.4 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 229 M USD -15.2%
Marketable Securities, Current 89.4 M USD
Accounts Receivable, after Allowance for Credit Loss, Current 175 M USD -2.48%
Inventory, Net 31.3 M USD -4.92%
Other Assets, Current 93 K USD +63.2%
Assets, Current 539 M USD +8.22%
Deferred Income Tax Assets, Net 30.7 M USD +28%
Property, Plant and Equipment, Net 15.5 M USD -18.1%
Operating Lease, Right-of-Use Asset 5.81 M USD -12.7%
Intangible Assets, Net (Excluding Goodwill) 387 M USD -26.9%
Goodwill 134 M USD 0%
Other Assets, Noncurrent 954 K USD +997%
Assets 1.11 B USD -8.24%
Accounts Payable, Current 6.02 M USD +101%
Employee-related Liabilities, Current 968 K USD +14.8%
Accrued Liabilities, Current 38.2 M USD +56.3%
Liabilities, Current 446 M USD +8.17%
Deferred Income Tax Liabilities, Net 71.2 M USD -24.7%
Operating Lease, Liability, Noncurrent 5.86 M USD -14.7%
Liabilities 892 M USD -13.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -124 K USD
Retained Earnings (Accumulated Deficit) -205 M USD +31.2%
Stockholders' Equity Attributable to Parent 222 M USD +23.6%
Liabilities and Equity 1.11 B USD -8.24%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 61.9 M USD +124%
Net Cash Provided by (Used in) Financing Activities -54.1 M USD -179%
Net Cash Provided by (Used in) Investing Activities -18.1 M USD -10200%
Common Stock, Shares Authorized 100 M shares 0%
Common Stock, Shares, Issued 39 M shares +3.21%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 230 M USD -15.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 17.5 M USD -10.4%
Deferred Tax Assets, Valuation Allowance 5.78 M USD +10%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 103 M USD -16.6%
Operating Lease, Liability 7.11 M USD -13.5%
Depreciation 917 K USD +12.2%
Payments to Acquire Property, Plant, and Equipment 568 K USD +223%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 93.2 M USD
Lessee, Operating Lease, Liability, to be Paid 8.49 M USD -15.7%
Property, Plant and Equipment, Gross 25.7 M USD -0.71%
Operating Lease, Liability, Current 1.01 M USD -2.78%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.44 M USD +2.72%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.4 M USD -11.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) -4.41 M USD -9491%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.38 M USD -25.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.47 M USD +2.65%
Deferred Tax Assets, Operating Loss Carryforwards 33.8 M USD -40.7%
Deferred Federal Income Tax Expense (Benefit) -1.4 M USD +69.7%
Preferred Stock, Shares Authorized 5 M shares 0%
Unrecognized Tax Benefits 11.3 M USD -0.83%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.49 M USD +1.02%
Operating Lease, Payments 1.59 M USD +1.08%
Additional Paid in Capital 565 M USD +4.58%
Current State and Local Tax Expense (Benefit) 8.23 M USD +81.2%
Current Federal Tax Expense (Benefit) 21.5 M USD +12854%
Amortization of Intangible Assets 34.5 M USD -7.87%
Deferred Tax Assets, Net of Valuation Allowance 97.4 M USD -17.8%
Share-based Payment Arrangement, Expense 28.6 M USD +25.5%
Deferred State and Local Income Tax Expense (Benefit) -752 K USD +80.8%
Interest Expense 79.3 M USD +0.56%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%